Evidence map›Paper›PMID 41059916›Full record

ArticleFunction (Oxford, England)2025

Sequentially Constrained Randomization in Preclinical Animal Studies.

Joseph Rigdon, Michael Walkup, David Amar, Matthew T Wheeler, Laurie J Goodyear, Sue Bodine, Karyn Esser, Denise Esserman, Michael E Miller

Abstract read
In one paragraph

Article in Function (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joseph RigdonDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, NC, 27157, USA.ORCID 0000-0001-6265-0752
Michael WalkupDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, NC, 27157, USA.
David AmarDepartment of Human Molecular Genetics Biochemistry, Tel Aviv University School of Computer Science, Tel Aviv, 6997801, Israel.
Matthew T WheelerDivision of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-8721-3022
Laurie J GoodyearSection on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston MA 02215, USA.
Sue BodineOklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.ORCID 0000-0002-5742-9145
Karyn EsserDepartment of Physiology and Aging, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Denise EssermanDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA.
Michael E MillerDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC, 27157, USA.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
MoTrPAC Supplemental Funding for MillerU24AR071113 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jon Peter Durda, Karyn A Esser · 2017 to 2026
$28.8M
PAGES: Physical Activity Genomics, Epigenomics/transcriptomics SiteU24DK112331 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI STUART C. SEALFON, Martin John Walsh · 2017 to 2026
$18.5M
Stanford/Salk MoTrPAC Site for Genomes, Epigenomes and TranscriptomesU24DK112348 · NIDDK · STANFORD UNIVERSITY · PI Stephen Montgomery, MICHAEL P. SNYDER · 2017 to 2026
$18.4M
Molecular Transducers of Physical Activity Consortium Adult Clinical CenterU01AR071130 · NIAMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUSI, NICOLAS, RASMUSSEN, BLAKE B · 2017 to 2024
$17.7M
ProMoTr: A Proteomics Center for MoTrPACU24DK112349 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI Joshua N. Adkins · 2017 to 2026
$17.5M
The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical CenterU01AR071133 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUFORD, THOMAS W, GOODPASTER, BRET H · 2017 to 2024
$16.7M
A Biochemical Roadmap of Exercise Signaling - Pilot Project for MoTrPAC ConsortiumU24DK112340 · NIDDK · BROAD INSTITUTE, INC. · PI STEVEN A CARR, Clary B Clish · 2017 to 2026
$16.2M
MoTrPAC DXA Quality ControlU01AR071128 · NIAMS · DUKE UNIVERSITY · PI HOUMARD, JOSEPH A, KRAUS, WILLIAM E · 2017 to 2025
$15.2M
Molecular Transducers of Physical Activity Consortium - Colorado Clinical CenterU01AR071124 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI KOHRT, WENDY M · 2017 to 2024
$14.5M
Stanford MoTrPAC Bioinformatics CenterU24OD026629 · OD · STANFORD UNIVERSITY · PI ASHLEY, EUAN A, WHEELER, MATTHEW THOMAS · 2018 to 2023
$13.9M
Michigan MoTrPAC Chemical Analysis Site (MiCAS)U24DK112342 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES F BURANT, CHARLES ROBERT EVANS · 2017 to 2026
$12.6M
NIAMS NIH HHS U01 AR071124NIAMS NIH HHS U01 AR071128NIAMS NIH HHS U01 AR071130NIAMS NIH HHS U01 AR071133NIAMS NIH HHS U01 AR071150NIAMS NIH HHS U01 AR071158NIAMS NIH HHS U01 AR071160NIAMS NIH HHS U24 AR071113NIA NIH HHS U01 AG055133NIA NIH HHS U01 AG055135NIA NIH HHS U01 AG055137NIA NIH HHS U01 AG070928NIA NIH HHS U01 AG070959NIA NIH HHS U01 AG070960NIDDK NIH HHS P30 DK036836NIDDK NIH HHS U24 DK112326NIDDK NIH HHS U24 DK112331NIDDK NIH HHS U24 DK112340NIDDK NIH HHS U24 DK112341NIDDK NIH HHS U24 DK112342NIDDK NIH HHS U24 DK112348NIDDK NIH HHS U24 DK112349NIH HHS U01AG055133NIH HHS U01AG055135NIH HHS U01AG055137NIH HHS U01AG070928NIH HHS U01AG070959NIH HHS U01AG070960NIH HHS U01AR071124NIH HHS U01AR071128NIH HHS U01AR071130NIH HHS U01AR071133NIH HHS U01AR071150NIH HHS U01AR071158NIH HHS U01AR071160NIH HHS U24AR071113NIH HHS U24DK112326NIH HHS U24DK112331NIH HHS U24DK112340NIH HHS U24DK112341NIH HHS U24DK112342NIH HHS U24DK112348NIH HHS U24DK112349NIH HHS U24 OD026629NIH HHS U24OD026629
6 · The paper itself

Abstract

Randomization is a key component to scientific inquiry as it facilitates unbiased estimation of treatment effects via balancing of measured and unmeasured prognostic variables across treatment groups. Recent reports have noted that randomization is lacking in animal studies, threatening internal validity. Animal studies often involve rodents (mice or rats) sent in small batches to laboratories or bred on site in litters. Randomizing half of each batch to treatment and half to control (simple randomization) is a viable strategy to implementing randomization in animal studies, however experimenters may be concerned about chance imbalances, given the smaller sample sizes utilized in animal studies, in key prognostic variables, eg, baseline weight. Constrained randomization, wherein key prognostic factors are balanced within each batch, may offer benefits over simple randomization, especially if it were sequential, ie, could take balance of previous batches into account when randomly assigning treatment in current batch. Adjusting for prognostic variables in a statistical model is a way to address imbalances, independent of choice of randomization scheme. In simulations designed to mimic realistic scenarios, all methods of randomization tested led to unbiased treatment effect estimation, with model adjustment reducing standard errors and improving statistical power in all scenarios. Treatment effects in unadjusted and adjusted models were nearly an order of magnitude closer to each other in sequentially constrained randomization compared to simple randomization, yielding more robust findings.

Indexed as

Research DesignAnimalsComputer SimulationMiceModels, StatisticalRandom AllocationRatsbatchesrandomizationstatistical modelingtreatment effect

Identifiers

PMID41059916
PMCPMC12560233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.